Internship

Machine Learning Intern

Confirmed live in the last 24 hours

Generate Biomedicines

Generate Biomedicines

201-500 employees

Generates novel medicines using generative biology

AI & Machine Learning
Biotechnology

Cambridge, MA, USA

Onsite at our location in Somerville, Massachusetts.

Category
Applied Machine Learning
AI & Machine Learning
Required Skills
LLM
Python
Tensorflow
R
Pytorch
Machine Learning
NumPy
Requirements
  • Current PhD Student in Applied Math, Computer Science, Computational Biology, Statistics, or a related field is required for this internship
  • Experience with conceiving of, implementing, and developing novel Machine Learning methodology with generative modeling and/or LLM-based workflows
  • Experience with modern deep learning frameworks such as Pytorch, JAX, or Tensorflow
  • Proficiency in Python and experience analyzing data with Numpy/Scipy, R, or similar
Responsibilities
  • Contribute to ML research advancing the state of art in machine learning of sequence, structure, and function, its application to therapeutic generation, and its acceleration with agentic approaches to science
  • Work with a mentor to advance a summer research project while collaborating and developing high-quality code in a cross-functional team
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. The company studies millions of proteins to learn how they function and then uses this knowledge to design new medicines tailored for specific therapeutic needs. Their main product, The Generate Platform, allows for the rapid production of medicines across various therapeutic areas, making the drug discovery process more efficient compared to traditional methods. Unlike many competitors, Generate Biomedicines emphasizes a proactive approach to medicine creation and aims to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating and testing proteins, ultimately providing innovative therapeutic solutions to clients in the biotechnology and pharmaceutical sectors.

Company Stage

Series C

Total Funding

$674.1M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Generative AI is enhancing Generate Biomedicines' drug discovery capabilities.
  • Strategic alliances, like with Novartis, leverage AI for drug development.
  • Samsung's investment indicates strong market confidence in Generate Biomedicines.

What critics are saying

  • Intellectual property disputes may arise as the generative biology platform expands.
  • Technological advancements may render current platforms obsolete without continuous innovation.
  • Reliance on partnerships could pose risks if collaborations don't meet expectations.

What makes Generate Biomedicines unique

  • Generate Biomedicines uses generative biology to create protein-based medicines efficiently.
  • The Generate Platform allows rapid production of medicines across multiple therapeutic areas.
  • The company integrates machine learning with biological engineering for innovative drug discovery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours